收费全文 | 51344篇 |
免费 | 3063篇 |
国内免费 | 192篇 |
耳鼻咽喉 | 709篇 |
儿科学 | 1295篇 |
妇产科学 | 1031篇 |
基础医学 | 7390篇 |
口腔科学 | 968篇 |
临床医学 | 4761篇 |
内科学 | 11520篇 |
皮肤病学 | 908篇 |
神经病学 | 4663篇 |
特种医学 | 2115篇 |
外国民族医学 | 3篇 |
外科学 | 8528篇 |
综合类 | 321篇 |
一般理论 | 27篇 |
预防医学 | 2995篇 |
眼科学 | 695篇 |
药学 | 2996篇 |
中国医学 | 57篇 |
肿瘤学 | 3617篇 |
2023年 | 246篇 |
2022年 | 506篇 |
2021年 | 1099篇 |
2020年 | 683篇 |
2019年 | 1061篇 |
2018年 | 1297篇 |
2017年 | 958篇 |
2016年 | 1027篇 |
2015年 | 1155篇 |
2014年 | 1694篇 |
2013年 | 2310篇 |
2012年 | 3317篇 |
2011年 | 3539篇 |
2010年 | 1986篇 |
2009年 | 1982篇 |
2008年 | 3100篇 |
2007年 | 3250篇 |
2006年 | 3070篇 |
2005年 | 2957篇 |
2004年 | 2681篇 |
2003年 | 2526篇 |
2002年 | 2376篇 |
2001年 | 823篇 |
2000年 | 672篇 |
1999年 | 696篇 |
1998年 | 559篇 |
1997年 | 472篇 |
1996年 | 386篇 |
1995年 | 339篇 |
1994年 | 306篇 |
1993年 | 291篇 |
1992年 | 334篇 |
1991年 | 411篇 |
1990年 | 352篇 |
1989年 | 351篇 |
1988年 | 309篇 |
1987年 | 291篇 |
1986年 | 302篇 |
1985年 | 316篇 |
1984年 | 250篇 |
1983年 | 243篇 |
1982年 | 187篇 |
1981年 | 176篇 |
1980年 | 169篇 |
1979年 | 232篇 |
1978年 | 167篇 |
1975年 | 169篇 |
1974年 | 174篇 |
1973年 | 152篇 |
1972年 | 149篇 |
![点击此处可从《Academic emergency medicine》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Objectives
The objective was to develop a patient decision aid (DA) to promote shared decision making (SDM) for stable, alert patients who present to the emergency department (ED) with syncope.Methods
Using input from patients, clinicians, and experts in the field of syncope, health care design, and SDM, we created a prototype of a paper‐based DA to engage patients in the disposition decision (admission vs. discharge) after an unremarkable ED evaluation for syncope. In phase 1, we conducted one‐on‐one semistructured exploratory interviews with 10 emergency physicians and 10 ED syncope patients. In phase 2, we conducted one‐on‐one directed interviews with 15 emergency care clinicians, five cardiologists, and 12 ED syncope patients to get detailed feedback on DA content and design. We iteratively modified the aid using feedback from each interviewee until clarity and usability had been optimized.Results
The 11 × 17‐inch, paper‐based DA, titled SynDA, includes four sections: 1) explanation of syncope, 2) explanation of future risks, 3) personalized 30‐day risk estimate, and 4) disposition options. The personalized risk estimate is calculated using a recently published syncope risk‐stratification tool. This risk estimate is stated in natural frequency and graphically displayed using a 100‐person color‐coded pictogram. Patient‐oriented questions are included to stimulate dialogue between patient and clinician. At the end of the development process, patient and physician participants expressed satisfaction with the clarity and usability of the DA.Conclusions
We iteratively developed an evidence‐based DA to facilitate SDM for alert syncope patients after an unremarkable ED evaluation. Further testing is required to determine its effects on patient care. This DA has the potential to improve care for syncope patients and promote patient‐centered care in emergency medicine.Areas covered: The advent of new direct-acting antiviral agents that achieve very high rates of sustained virologic response (representing virologic cure) with short (i.e. 8–12 weeks) regimens has revolutionized the field of HCV treatment and led to the development of global elimination goals for HCV transmission and mortality. However, information on their safety during pregnancy and efficacy in preventing mother-to-child transmission is lacking. Currently, there are no approved treatment regimens with these antiviral agents for children younger than 12 years of age.
Expert commentary: If these agents are shown to be safe during pregnancy and effective in preventing transmission to the infant, screening of pregnant women and antenatal treatment of those infected, could pave the way for eliminating pediatric HCV infection- particularly as these drugs become less costly and more accessible. Treatment of infected children when indicated, along with universal safe health care practices, can further pediatric HCV elimination. 相似文献
Background
Preoperative anemia and allogeneic blood transfusions (ABTs) may affect outcomes in cancer surgery. The prevalence of anemia, the use of ABTs, the risks of transfusions, lengths of stay and mortality of oncological patients undergoing radical cystectomy were investigated in three University Hospitals in Germany.Patients and Methods
Hospital records of 220 consecutive patients undergoing radical cystectomy from 2010 to 2012 were retrospectively analyzed for independent risk factors of ABT and unfavorable outcomes (readmission, increased length of stay (LOS) or death) using multivariate regression analysis.Results
Preoperative anemia was present in 40%. 70% of patients received blood transfusions. Low preoperative and intraoperative nadir hemoglobin levels were associated with receipt of ABT (OR 1.33, P?=?0.04 and OR 2.94, P?<?0.001 respectively). Transfusion of ten or more red blood cell units (RBCs) during the entire hospital stay was a predictor of an increased LOS (P?<?0.001) and death (OR 52, 95%CI [5.9, 461.3], P?<?0.001), compared to non-transfused patients. Preoperative ABT and ASA scores were associated with ≥10RBCs.Conclusion
Anemic patients undergoing radical cystectomy had a high risk to receive ABTs. Preoperative transfusions and transfusion of ≥10RBCs during the entire hospital stay may increase patient`s mortality.Prospective, randomized controlled studies have to follow this study. 相似文献Areas covered: In this narrative review of recent clinical studies investigating metabolomic markers in adult patients presenting with acute infectious disease, we mainly focused on patients with sepsis and lower respiratory tract infections. Currently, there is a growing body of literature showing that single metabolites from distinct metabolic pathways, as well as more complex metabolomic signatures are associated with disease severity and outcome in patients with systemic infections. These pathways include, among others, metabolomic markers of oxidative stress, steroid hormone and amino acid pathways, and nutritional markers.
Expert commentary: Metabolic profiling has great potential to optimize patient management, to provide new targets for individual therapy and thereby improve survival of patients. At this stage, research mainly focused on the identification of new predictive signatures and less on metabolic determinants to predict treatment response. The transition from observational studies to implementation of novel markers into clinical practice is the next crucial step to prove the usefulness of metabolomic markers in patient care. 相似文献